公司資料
Curis Inc 股價、新聞與催化劑
- 股票代碼:
- CRIS
- 交易所:
- NASDAQ
- 產業:
- Biopharma
- 所在地:
- United States
股票表現
1.80 USD (0.00%)
收盤價
最後更新: 2026年8月17日
19.6M USD
市值
股價為何變動
As of Aug 17, 2026, CRIS was little changed and closed at $1.80. No new same-company headline was identified in the current news window.
公司概覽
業務概覽
Curis is a biotechnology company focused on oncology and immune-modulating therapies. Its story has been shaped by a small pipeline and repeated efforts to create durable value.
所在地與產業分類
Headquartered in the United States and listed on NASDAQ, Curis sits in specialty biotechnology.
商業模式特徵
The company depends on clinical data, strategic focus, and the ability to build a more durable oncology and immunology story.
生技產業定位
Curis is a small-cap catalyst name whose valuation depends on development progress and strategic clarity.
未來催化劑
- Curis’s catalysts are oncology and immunotherapy pipeline updates, plus any strategic step that clarifies what still has value. The company needs a cleaner development path to matter again.
近期新聞
- 01
- 02
- 03
- 04
- 05
相似股票
商業成熟度、治療領域或催化劑模式相近的同業公司。